公司概覽
業務類別 --
業務概覽 Orthocell Ltd is a regenerative medicine company. The company is engaged in the development and commercialization of biological medical devices, cell therapies, and related technologies to address unmet clinical needs in human health in the regenerative medicine industry. Its product includes Striate plus; Remplir which is a collagen wrap used in peripheral nerve repair; and OrthoACI an implantation used for the treatment of articular cartilage defects in the knee and ankle. It also has various other products in its pipeline such as Tendon Cell Therapy and Collagen Medical Device Platform.
公司地址 90 South Street, Building 191, Murdoch University, Murdoch, Perth, WA, AUS, 6150
電話號碼 +61 893602888
傳真號碼 +61 893602899
公司網頁 https://www.orthocell.com.au
員工數量 --
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Paul Anderson Director, Managing Director and Chief Executive Officer -- 03/10/2025
 
董事會成員
董事會 職務 更新日期
Dr. Ravi I. Thadhani Independent Director 03/10/2025
Mr. Paul Anderson Director, Managing Director and Chief Executive Officer 03/10/2025
Professor Fiona Wood Independent Director 03/10/2025
Mr. John Van Der Wielen Chairman of the Board 03/10/2025
 
所屬ETF (更新日期: 02/05/2026 04:27)
代號 名稱 佔比% 持有日期
ISCFiShares MSCI Intl Small-Cap Mltfct ETF0.22%28/04/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.